LUMENS Bios Holds Extraordinary Shareholder Meeting

• LUMENS Bios shareholders approved an 80% capital reduction at an extraordinary general meeting on Nov. 9, 2026.
• The plan consolidates five registered common shares into one without payment to shareholders, covering accumulated losses to improve financial strength.
• The approved reduction would lower the share count from 25,837,248 to 5,167,449.
• The capital reduction is scheduled for Nov. 25, 2026, with new shares expected to list on Dec. 16, 2026.
• Shareholders also approved the appointment of Ryu Hwan-yeol as a full-time auditor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LUMENS Bios Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261109900253), on November 09, 2026, and is solely responsible for the information contained therein.